Evidence map›Paper›PMID 41208835›Full record

ArticleBiochemistry and biophysics reports2025

Clinical Quantitative Method Development of serum indoxyl sulfate (IS) assay using LC-MS/MS.

Sohei Kobayashi, Kazuyuki Matsushita, Kenji Kawasaki, Masanori Seimiya

Abstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sohei KobayashiDepartment of Medical Technology & Sciences, School of Health Sciences at Narita, International University of Health and Welfare, Chiba, Japan.
Kazuyuki MatsushitaDepartment of Laboratory Medicine & Division of Clinical Genetics, Chiba University Hospital, Chiba, Japan.
Kenji KawasakiDepartment of Laboratory Medicine & Division of Clinical Genetics, Chiba University Hospital, Chiba, Japan.
Masanori SeimiyaDepartment of Medical Technology & Sciences, School of Health Sciences at Narita, International University of Health and Welfare, Chiba, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Indoxyl sulfate (IS) accumulates in the blood with decreases in the voided volume due to a decline in renal function and promotes the progression of renal failure. Assay reagents for IS are marketed by several companies, but they have not been standardized because of the absence of a standard assay method. In this study, the performance of the LC-MS/MS (liquid chromatography tandem mass spectrometry) was evaluated for the establishment of a standard assay method. Methods: The same analytical procedure was performed by two examiners using the AB SCIEX QTRAP® 4500 LC-MS/MS System. A calibration curve was prepared according to the target analyte (IS)/internal standard: 3-Indoxyl sulfate-d4 potassium salt (IS-d4) peak area ratio, and the linearity, reproducibility, selectivity tests, interferent tests, limit of blank (LOB), limit of detection (LOD), lower limit of quantification (LLOQ), and correlations were evaluated. Results: By dilution tests of IS standard solution, linearity (R Discussion: The basic performance of this method was satisfactory. Also, because excellent precision was obtained in both examiners, the stability of the assay method was also suggested to be guaranteed. This method is considered useful as a reference method for IS assay.

Indexed as

Analytical validationChronic kidney disease (CKD)Clinical quantitative method developmentProtein-bound uremic toxins (PBUT)Reference assay method

Identifiers

PMID41208835
PMCPMC12593637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.